Articles Patient experience: living with glaucoma This week is World Glaucoma Week, held annually to raise awareness of eye disease glaucoma, which is the most common cause of irreversible blindness in the world today.
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.